Fish-oil lipid emulsions may prevent ROP

Article

Premature infants with very low birth weight who receive an intravenous fat emulsion containing fish oil are less likely to develop retinopathy of prematurity (ROP), according to a recent study.

Premature infants with very low birth weight who receive an intravenous fat emulsion containing fish oil are less likely to develop retinopathy of prematurity (ROP), according to a study recently published in Early Human Development.

For this randomized controlled study, researchers sought to compare the effects of two lipid emulsions on the development of ROP in very low birth weight infants (N = 80). Infants received one of two lipid emulsions: group 1 (n = 40) received a fish-oil-based lipid emulsion (SmofLipid), and group 2 (n = 40) received a soybean oil based lipid emulsion (Intralipid).

Maternal and perinatal characteristics were similar in both groups, as were median duration of parenteral nutrition (14 days for both) and hospitalization (34 days for both). Complete blood counts, triglyceride levels, liver and kidney function tests before and after parenteral nutrition did not differ between the two groups.

ROP was diagnosed in two patients in group 1 and in 13 patients in group 2 (5.0% vs 32.5%, respectively; OR: 9.1, 95% CI: 1.9-43.8; P = 0.004). One patient in each group required laser photocoagulation. Upon multivariate analysis, researchers concluded that only receiving fish-oil emulsion in parenteral nutrition decreased the risk of developing retinopathy of prematurity (OR: 0.76, 95% CI: 0.006-0.911; P = 0.04).

"Although preterm infants benefit from diets supplemented with DHA very early in visual development, there are very limited data of DHA enriched parenteral nutrition in the first days of life in preterm infants," noted the authors. "In conclusion, fish-oil lipid emulsions may be preventive for ROP development in preterm infants requiring total parenteral nutrition. If these infants are minimally fed by enteral route and receive routine total parenteral nutrition that does not contain DHA, this condition might have an additive effect on ROP development. Multicentre studies are needed to assess this effect in preterm infants," they concluded.

To view the full text of this study, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.